Public Health Security and Bioterrorism
Preparedness and Response Act of 2002
January 2002, U.S. Congress
Battling Bioterrorism: Why Time-Information-Sharing Between Local,
State and Federal Governments is the Key to Protecting Public Health
December
14, 2001, House of Representatives
July 25, 2002 - HOUSE
INTERNATIONAL RELATIONS COMMITTEE - Full Committee - "Loose
Nukes, Biological Terrorism and Chemical Warfare: Using Russian
Debt to Enhance Security.
Testimony
of Henry J. Hyde, Chairman
Testimony
of the Honorable Ellen O. Tauscher, US House
of Representatives
Testimony
of Mr. Alan P. Larson, Undersecretary of
State for Economic, Business and Agricultural Affairs
Testimony
of Dr. James D. Fuller, Director, Defense
Nuclear Nonproliferation Programs
Testimony
of Mr. Charles B. Curtis, President, Nuclear
Threat Innitiative
Testimony
of Dr. Constantine C. Menges, Senior Fellow,
The Hudson Institute
June 28, 2002 - SENATE GOVERNMENTAL AFFAIRS
COMMITTEE - Full Committee - A hearing to examine how a Department
of Homeland Security should address weapons of mass destruction and
relevant science and technology, research and development, and public
health issues.
Testimony
of Lewis M. Branscomb, PhD, Professor Emeritus,
Public Policy and Corporate Management, JFK School of Government,
Harvard University
Testimony
of Margaret A. Hamburg, M.D., Vice President
for Biological Programs, Nuclear Threat Initiative
Testimony
of the Honorable John T. Hamre, President
and Cief Executive Officer, Center for Strategic International
Studies
Testimony
of Janet Heinrich, Director, Health Care
and Public Health Issues, United States General Accounting
Office
Testimony
of William J. Madia, PhD, Director, Oak Ridge
National Laboratory, Executive Vice President, Battelle Memorial
Institute
Testimony
of J. Leighton Read, M.D., General Partner,
Alloy Ventures
June 26, 2002 - SENATE JUDICIARY COMMITTE -
Technology, Terrorism and Government Information Subcommittee - Protecting
the Homeland: The President's Proposal for Reorganizing Our Homeland
Security Infrastructure.
Testimony
of the Honorable Tom Ridge, Director, Transition
Planning Office for the Department of Homeland Security
Testimony
of the Honorable Patrick Leahy, US Senate
Testimony
of the Honorable Orrin Hatch, US Senate
June 25, 2002 - SENATE JUDICIARY COMMITTE -
Technology, Terrorism and Government Information Subcommittee - Protecting
the Homeland: The President's Proposal for Reorganizing Our Homeland
Security Infrastructure.
Testimony
of the Honorable James S. Gilmore, III, Former
Governor of the Commonwealth of Virginia and Chairman of the
Advisory Panel to Assess the Capabilities for Domestic Response
to Terrorism Involving Weapons of Mass Destruction
Testimony
of the Honorable David M. Walker, Comptroller
General, General Accounting Office
Testimony
of Mr. Paul C. Light, Vice President and
Director, Governmental Studies, The Brookings Institution
Testimony
of Mr.Ivo H. Daalder, Senior Fellow, Foreign
Policy Studies, The Brookings Institution
Testimony
of Mr.Ivan Eland, Director, Defense Policy
Studies, CATO Institute
Testimony
of the Honorable Orrin Hatch, US Senate
June 11, 2002 - HOUSE GOVERNMENTAL REFORM COMMITTEE
- National Security Subcommittee - Combating Terrorism: Improving
the Federal Response. A hearing to examine the bill, H.R. 4660, The
National Homeland Security and Combating Terrorism Act of 2002, introduced
to establish a Department of Homeland Security and the National Office
for Combating Terrorism.
Testimony
of the Honorable Mac Thornberry, US House of
Representatives
Testimony
of the Honorable Jane Harman, US House of Representatives
Testimony
of the Honorable Jim Gibbons, US House of Representatives
Testimony
of the Honorable Ellen O. Tauscher, US House of Representatives
Testimony
of the Honorable Joseph Lieberman, US Senate
Testimony
of Admiral Thomas Collings, Commandant, United States Coast
Guard, Department of Transportation
Testimony
of Mr. Bruce Baughman, Director, Office of National Preparedness,
Federal Emergency Management Agency
Testimony
of Mr. Douglas Browning, Deputy Commissioner, US Customs
Testimony
of Mr. Robert Acord, Administrator, Animal and Plant Health
Inspection Service, Department of Agriculture
Testimony
of Mr. John Tritak, Director, Critical Infrastructure Assurance
Office, Bureau of Industry Security, Department of Commerce
Testimony
of Mr. Larry Mefford, Assistant Director, Cyber Division, Federal
Bureau of Investigation
April 18, 2002 - INTERNATIONAL SECURITY, PROLIFERATION,
AND FEDERAL SERVICES SUBCOMMITTEE - A hearing regarding, The State
of Public Health Preparedness for Terrorism Involving Weapons of
Mass Destruction: A Six Month Report Card
Testimony
of the Honorable Tommy Thompson, Secretary,
United States Department of Health and Human Services
Testimony
of Margaret A. Hamburg, M.D., Vice President for Biological
Programs Nuclear Threat Initiative
Testimony
of Thomas V. Inglesby, M.D., Deputy Director, Johns Hopkins
Center for Civilian Biodefense Strategies
Testimony
of Thomas L. Milne, Executive Director, Governance Support
Team, National Association of County and City Health Officials
April 10, 2002 - Emerging Threats Subcommittee
- To receive testimony on technology for combating terrorism and
weapons of mass destruction in review of the Defense Authorization
Request for Fiscal Year 2003
Testimony
of the Honorable Ronald M. Sega, Director,
Defense Research and Engineering
Testimony
of the Honorable John H. Marburger, III, Director,
Office of Science and Technology Policy
Testimony
of the Honorable Dale Klein, Assistant
to the Secretary of Defense for Nuclear and Chemical and Biological
Defense Programs
Testimony
of Dr. Stephen M. Younger, Director,
Defense Threat Reduction Agency
Testimony
of Dr. Robert E. Waldron, Assistant
Deputy Administrator for Nonproliferation Research and Engineering,
Department of Energy/National Nuclear Security Administration
Testimony
submitted by Rear Admiral Jay M. Cohen, Chief
of Naval Research
Testimony
submitted by Dr. A. Michael Andrews II, Deputy
Assistant Secretary of the Army for Research and Technology
Testimony
submitted by Dr. Tony Tether, Director,
Defense Advanced Research Projects Agency
Testimony
submitted by the Department of the Air Force
March 21, 2002 - HOUSE GOVERNMENTAL REFORM
COMMITTEE – National Security Subcommittee - To hear testimony
on combating terrorism and protecting the United States, Part II.
Testimony
of Mr. Peter Vergo, Special Assistant for Homeland Security,
Office of the Secretary of Defense
Testimony
of Dr. William Raub, Deputy Director, Office of Public
Health Preparedness, Department of Health and Human Services
Testimony
of Mr. Kenneth O. Burris, Director, Region IV, (Atlanta),
Federal Emergency Management Agency
Testimony
of Mr. James Caruso, Deputy Assistant Director for Counter-terrorism,
Federal Bureau of Investigation
Testimony
of Mr. Joseph R. Greene, Deputy Associate Field Commissioner
for Field, Operations, Immigration and Naturalization Service
Testimony
of Stephen J. McHale, Deputy Under Secretary of Transportation
for Security Transportation Security Administration, Department
of Transportation
March 19, 2002 - SENATE FOREGIN RELATIONS COMMITTEE
- To hear testimony on reducing the threat of chemical and biological
weapons. Electronic testimony is not yet available. For further information,
please contact the Senate Foreign Relations Committee at (202) 224-4651.
March 12, 2002 - HOUSE GOVERNMENTAL REFORM
COMMITTEE – National Security Subcommittee - To hear testimony
on combating terrorism and protecting the United States, Part I
Testimony
of Governor Frank Keating, Governor of Oklahoma
Testimony
of the Honorable Edwin Meese III, Former Attorney General,
Co-Chairman, Homeland Security Task Force, The Heritage Foundation
Testimony
of Mr. Randall J. Larsen, Director, ANSER Institute for Homeland
Security
Testimony
of Mr. Joseph Cirincione, Director, Nonproliferation Project,
Carnegie Endowment for International Peace
Testimony
of Henry L. Hinton, Managing Director, Defense Capabilities
and Management, General Accounting Office
March 6, 2002 - SENATE ARMED SERVICES COMMITTEE
- Emerging Threats and Capabilities Subcommittee - To receive testimony
on the nonproliferation programs of the Department of Energy and
the Cooperative Threat Reduction program of the Department of Defense
in review of the Defense Authorization Request for Fiscal Year 2003.
Testimony
of the Honorable J. D. Crouch, II, Assistant Secretary of
Defense for International Security Policy
Testimony
of Ambassador Linton F. Brooks, Deputy Administrator for
Defense Nuclear Nonproliferation National Nuclear Security Administration
February 27, 2002 - SENATE ARMED SERVICES COMMITTEE
- Emerging Threats and Capabilities Subcommittee - To receive testimony
regarding the weapons of mass destruction capabilities of Iraq.
Testimony
of Anthony H. Cordesman, Arleigh Burke Chair and Senior Fellow,
Strategic Assessment, Center for Strategic and International
Studies
Testimony
of Charles A. Duelfer, Visiting Resident Scholar, Center
for Strategic and International Studies
February 12, 2002 - SENATE GOVERNMENTAL AFFAIRS
COMMITTEE - International Security, Proliferation and Federal Services
Subcommittee - Hearing to consider Multilateral Non-proliferation
Regimes, Weapons of Mass Destruction Technologies, and the War on
Terrorism
Testimony
of Ms. Elisa D. Harris, Research Fellow, Center for International
and Security Studies
Testimony
of Dr. Amy E. Smithson, Senior Associate, The Henry L. Stimson
Center
Testimony
of Dr. Jim Walsh, Research Fellow, Belfer Center for Science
and International Affairs
Testimony
of Mr. Dennis Gormley, Senior Fellow, International Institute
for Strategic Studies
December 5, 2001 - HOUSE INTERNATIONAL RELATIONS
COMMITTEE – Full Committee - To consider bioterrorism and the
potential sources of anthrax.
Opening
statement of Chairman Hyde
Testimony
of Dr. Richard Spertzel, Consultant
Testimony
of Dr. Kenneth Alibek, President, Advanced Biosystems, Inc.
Testimony of Elisa D. Harris, Research Fellow, Center for International
and Security Studies at Maryland University
December 5, 2001 - HOUSE BUDGET COMMITTEE -
Re-Structuring Government for Homeland Security: Nuclear / Biological
/ Chemical Threats.
Testimony
of Dr. Scott Lillibridge, Special Assistant to the Secretary
for National Security and Emergency Management, U.S. Department
of Health and Human Services
Testimony
of Joseph Mahley, Director, Office of Security for the U.S.
Department of Energy
Testimony
of Mr. Ken Baker, Principal Deputy Administrator for Defense
Nuclear Nonproliferation, National Nuclear Security Administration,
U.S. Department of Energy.
December 5, 2001 - HOUSE SCIENCE COMMITTEE
- Full Committee - To consider the Science of Bioterrorism: Is the
Government Prepared?
Opening
statement of Chairman Boehlert
Testimony
of John H. Marburger, III Director, Office of Science and
Technology Policy
Testimony
of Linda Fisher, Deputy Administrator, U.S. Environmental
Protection Agency
Testimony
of Dr. Anna Johnson-Winegar, Deputy Assistant to the Secretary
of Defense for Chemical and Biological Defense
Testimony
of Dr. D.A. Henderson, Director, Office of Public Health
Preparedness, Department of Health and Human Services
November 29, 2001 - SENATE APPROPRIATIONS COMMITTE
- Labor, HHS, Education Subcommittee - A hearing to discuss "Funding
for Bioterrorism Prepardeness."
Opening
statement of Chairman Tom Harkin
Testimony
of Mr. Joseph LaValley, Mercy Medical Center
Testimony
of Joseph A. Barbera, M.D, Co-Director, The Institute for
Crisis, Disaster, and Risk Management, George Washington University
Testimony
of Dr. Kenneth Alibek, President, Advanced Biosystems, Inc.
Testimony
of Anthony Fauci, M.D., Director, National Institute of Allergy
and Infectious Diseases, National Institutes of Health, U.S.
Department of Health and Human Services
Testimony
of Jeffrey P. Koplan, M.D., M.P.H., Director, Centers for
Disease Control and Prevention, Department of Health and Human
Services
November 29, 2001 - House Committee on Government
Reform, Subcommittee on National Security, Veterans Affairs, and
International Relations, “Risk Communication: National Security
and Public Health”
Opening
Statement of Chairman Shays
Testimony
of the Honorable David Satcher, U.S. Surgeon General
Testimony of the Honorable C. Everett Koop, Former U.S. Surgeon General
Testimony
of Dr. Mohammad Akhter, Executive Director, American Public
Health Association
Testimony
of Dr. Joseph Waeckerle, Chairman, Nuclear Biological and
Chemical Weapons Antiterrorism Task Force, Editor and Chief,
Annals of Emergency Medicine, Representing the American College
of Emergency Physicians
November 29, 2001 - SENATE GOVERNMENTAL AFFAIRS
COMMITTEE -International Security, Proliferation and Federal Services
Subcommittee – Combating Proliferation of Weapons of Mass Destruction
(WMD) with Non-Proliferation Programs: Non-Proliferation Assistance
Coordination Act of 2001 (Part II).
Opening
statement of Senator Akaka
Testimony
of Mr. Vann H. Van Diepen, Deputy Assistant Secretary, Bureau
of Non-proliferation, Department of State
Testimony
of Mr. Kenneth E. Baker, Principal Assistant Deputy Administrator
for Defense Nuclear Nonproliferation, Department of Energy
Testimony
of Mr. Matthew S. Borman, Deputy Assistant Secretary, Bureau
of Export Administration, Department of Commerce
November 14, 2001 - SENATE GOVERNMENTAL AFFAIRS
COMMITTEE -International Security, Proliferation and Federal Services
Subcommittee -Combating Proliferation of Weapons of Mass Destruction
(WMD) with Non-Proliferation Programs: Non-Proliferation Assistance
Coordination Act of 2001 (Part I).
Opening
statement of Senator Akaka
Testimony
of Ms. Gary L. Jones, Director of Nuclear and Nonproliferation
Issues, GAO Division of Natural Resources and Environment
Testimony
of Ms. Laura Holgate, Vice President of the Russian Newly
Independent States Program, Nuclear Threat Initiative
Testimony of Mr. Leonard S. Spector, Deputy Director of the Center for
Nonproliferation Studies, Monterey Institute of International Studies
November 7, 2001 - SENATE GOVERNMENTAL AFFAIRS
COMMITTEE - International Security, Proliferation and Federal Services
Subcommittee - Current and Future Weapons of Mass Destruction (WMD)
Proliferation Threats
Testimony
of Dr. Michael L. Moodie, President, Chemical and Biological
Arms Control Institute
Testimony
of Dr. Johnathan Tucker, Director, Monterey Institute of
International Studies Center for Nonproliferation Studies, Chemical
and Biological Weapons
Testimony
of Ms. Rose Gottemoeller, Senior Associate, Carnegie Endowment
for International Peace
Testimony
of Dr. Richard Cupitt, Associate Director, Center for International
Trade and Security
Testimony of Dr. Jim Lewis, Senior Fellow and Director of Technology Policy
Center for Strategic and International Studies
Testimony
of Mr. Joseph A. Christoff, Director, GAO’s Office of
International Affairs and Trade
Testimony
of Dr. Gary Millholin, Director, Wisconsin Project on Nuclear
Arms Control
Closing
statement of Senator Akaka
November 7, 2001 - HOUSE GOVERNMENTAL REFORM
COMMITTEE – National Security Subcommittee - To consider Chemical
and Biological Defense: Department of Defense Medical Readiness
Statement
of Statement of Rep. Christopher Shays
Statement
of Nancy Kingsbury, United States General Accounting Office,
Managing Director, Applied Research and Methods
Honorable
William Winkenwerder, Jr., Assistant Secretary of Defense
for Health Affairs
November 2, 2001 - SENATE APPROPRIATIONS COMMITTE
- Labor, HHS, Education Subcommittee - To receive testimony regarding
smallpox issues. Please contact (202) 224-7230 for further information
October 25, 2001 - SENATE ARMED SERVICES COMMITTEE
- Emerging Threats and Capabilities Subcommitte - To receive testimony
on the Dark Winter scenario and bioterrorism. For further information,
please contact the Senate Armed Services Committee at (202) 224-3871.
October 23, 2001 - HOUSE GOVERNMENTAL REFORM
COMMITTEE - National Security Subcommittee - Biological Warfare Defense
Vaccine Research & Development Programs
Testimony
of Tommy G. Thompson, Secretary, U.S. Department of Health
and Human Services
Testimony of Dr. Anna Johnson-Winegar, Deputy Assistant to the Secretary
of Defense for Chemical/Biological Defense
Dr.
Nancy Kingsbury, Managing Director For Applied Research & Methods,
General Accounting Office
Testimony
of Stephen G. Sudovar, President and CEO, EluSys Therapeutics,
Inc
Una
S. Ryan, Ph.D., President & CEO, AVANT Immunotherapeutics,
Inc.
October 17, 2001 - SENATE GOVERNMENTAL AFFAIRS
COMMITTEE - International Security, Proliferation, and Federal Services
Subcommittee - To consider federal efforts to coordinate and prepare
the United States for bioterrorism: Are they ready
Testimony
of Tommy G. Thompson, Secretary, Department of Health and
Human Services
Testimony
of Michael D. Brown, Acting Director and General Counsel,
Office of General Counsel, Federal Emergency Management Agency
Testimony of Dr. Anna Johnson-Winegar, Deputy Assistant to the Secretary
of Defense for Chemical and Biological Defense
Testimony
of Maureen E. Dempsey, M.D., F.A.A. P., Director, Missouri
Department of Health and Senior Services
Testimony
of Margaret A. Hamburg, M.D., Vice President of Biological
Programs, Nuclear Threat Initiative
Testimony
of Gary W. McConnell, Director, Georgia Emergency Management
Agency
Testimony of Amy E. Smithson, Ph.D., Director, Chemical and Biological
Weapons
Nonproliferation Project, Henry L. Stimson Center
October 12, 2001 - HOUSE GOVERNMENTAL REFORM
COMMITTEE - National Security Subcommittee - Assessing the threat
of a biological weapons attack
Testimony
of Mr. Raymond Decker, Director, Defense Capabilities Management
Team, U.S. General Accounting Office
Testimony
of John Parachini, Policy Analyst, RAND Washington Office
Testimony
of Jerrold M. Post, M.D., The Elliott School of International
Affairs, George Washington University
October 9, 2001 - SENATE HEALTH, EDUCATION,
LABOR AND PENSIONS
COMMITTEE - Full Committee - To consider the most effective responses to threats
of bioterrorism
Opening
Statement of Hon. Edward M. Kennedy, Chairman
Opening
Statement of Hon. Bill Frist
Opening
Statement of Hon. Susan Collins
Testimony
of Donald A. Henderson, MD, MPH, Director, Johns Hopkins
Center for Civilian Biodefense Studies
Testimony
of Michael Osterholm, Ph.D., MPH, Director, Center for Infectious
Disease Research and Policy, University of Minnesota
Testimony
of Mohammad N. Akhter, MD, MPH, Executive Director, American
Public Health Association
October 3, 2001 - SENATE APPROPRIATIONS COMMITTE
- Labor, HHS, Education Subcommittee - To receive testimony regarding
the threat of bioterrorism.
Testimony
of Jonathan B. Tucker, Ph.D. Director, Chemical & Biological
Weapons Nonproliferation Program Center for Nonproliferation
Studies Monterey Institute of International Studies (Part I)
Testimony
of Jonathan B. Tucker, Ph.D. (Part II)
September 5, 2001 - SENATE FOREIGN RELATIONS
COMMITTEE - Full Committee - To consider the threat of bioterrorism
and the spread of infectious diseases. For further information, please
contact the Senate Foreign Relations Committee at (202) 224-4651.
July 23, 2001 - HOUSE GOVERNMENTAL REFORM COMMITTEE – National
Security Subcommittee - July 23, 2001 - A hearing on combating terrorism and
federal response to a biological weapons attack.
Opening
Statement of Rep. Christopher Shays
Testimony
of Governor Frank Keating (Oklahoma)
Testimony
of Sam Nunn, Chairman and Chief Executive Officer, Nuclear
Threat Initiative
Testimony of Dr. Margaret Hamburg, Vice President, Biological Programs
for the Nuclear Threat Initiative
Testimony of Mr. Jerome Hauer, Managing Director, Kroll Associates
Testimony of Major
General William A. Cugno, The Adjutant General of Connecticut
Testimony
of Dr. James M. Hughes, Director, National Center for Infectious
Diseases, Centers for Disease Control & Prevention
Testimony
of Dr. Patricia Quinlisk, Medical Director and State Epidemiologist,
Iowa Department of Public Health
Testimony of Dr.
Jeffrey S. Duchin, Chief, Communicable Disease Control,
Epidemiology and Immunization Section, Public Health, Seattle & King County,
Washington
July 10, 2001 - HOUSE GOVERNMENTAL REFORM COMMITTEE
- National Security Subcommittee - A hearing on the Biological Weapons
Convention Protocol: Status and Implications.
Opening
Statement of Rep. Christopher Shays
Opening
Statement of the Rep. Adam H. Putnam
Opening
Statement Rep. Dennis J. Kucinich
Opening
Statement Rep. John F. Tierney
Testimony
of Ambassador Donald A. Mahley, Special Negotiator for Chemical
and Biological Arms Control, Department of State
Testimony
of Dr. Edward Lacey, Principal Deputy Assistant Secretary
for Verification and Compliance, Department of State
Testimony
of Ambassador James Leonard, Former US Ambassador, United
Nations Conference on Disarmament
Testimony
of Ambassador Tibor Tóth, Hungary, Chairman, Ad Hoc
Group of the States Parties to the Biological Weapons Convention
Testimony
of Professor Graham S. Pearson, Visiting Professor of International
Security,
Department of Peace Studies, University of Bradford
June 5, 2001 - HOUSE GOVERNMENTAL REFORM COMMITTEE – National
Security Subcommittee - A hearing to discuss the status and implications
of the Biological and Chemical Convention Protocol.
Testimony
of Dr. Gillian R. Woollett, Associate Vice President, Biologics
and Biotechnology, Pharmaceutical Research and Manufacturers
of America
Testimony
of Mr. Alan P. Zelicoff, Senior Scientist, Nonproliferation
Initiatives, Sandia National Laboratories
Testimony
of Colonel Robert P. Kadlec, Professor of Military Strategy
and Operations,
National War College
Testimony of Dr.
Amy Smithson, Senior Associate, Henry L. Stimson Center
Testimony
of Dr. Barbara Hatch Rosenberg, Project Director, Chemical/Biological
Arms Control Federation of American Scientists
Testimony submitted for the Record by Dr. Mathew Meselson
May 10, 2001 - Before the United States Senate
Committee on Appropriations Subcommittee on Commerce, Justice, and
State, The Judiciary, and Related Agencies Joint Hearing on U.S.
Federal Efforts to Combat Terrorism
STATEMENT
OF CHIEF JOHN "JACK" FANNING,
New York City Fire Department
STATEMENT
OF MR. PETER LAPORTE, District of
Columbia Emergency Management Agency
STATEMENT
OF DR. STEPHEN CANTRILL, Denver Health
Medical Center
STATEMENT
OF DR. BERNADINE HEALY, President and
CEO, The American Red Cross
May 9, 2001- Before the United States Senate
Committee on Appropriations Subcommittee on Commerce, Justice, and
State, The Judiciary, and Related Agencies Joint Hearing on US Federal
Efforts to Combat Terrorism
STATEMENT
OF THE HONORABLE TOMMY THOMPSON, Secretary,
Dept. of Health and Human Services
STATEMENT
OF ATTORNEY GENERAL JOHN ASHCROFT
STATEMENT
OF DONALD L. EVANS, Secretary US Department
of Commerce
STATEMENT
OF THE HONORABLE ANN M. VENEMAN, Secretary,
Department of Agriculture
STATEMENT
OF THE HONORABLE COLIN POWELL, Secretary,
Department of State
STATEMENT
OF THE HONORABLE NORMAN Y. MINETA, Secretary,
Department of Transportation
STATEMENT
OF THE HONORABLE JOHN A. GORDON, Administrator,
National Nuclear Security Administration
February 7, 2001- Before
the Senate Select Committee on Intelligence on the "Worldwide Threat
2001: National Security in a Changing World" (as prepared for delivery)
STATEMENT
BY DIRECTOR OF CENTRAL INTELLIGENCE,
George J. Tenet
March 8, 2000 - Before the subcommittee on
National Security, Veterans Affairs, and international relations
committee on government reform, US House of Representatives, Committee
on Commerce.
TESTIMONY
OF STEPHEN M. OSTROFF, M.D., Associate Director for
infectious diseases, Centers for Diseases Control and Prevention,
Department of Health and Human Services
September 22, 1999 - Congress of the United
States, House of Representatives Committee on Government Reform,
Subcommittee on National Security, Veterans Affairs, and International
Relations, hearing on terrorism preparedness: medical first response.
TARA
O'TOOLE, MD, MPH, Senior Fellow, Center
for Civilian Biodefense Studies,
ELLEN
GORDON, Director, Iowa division of emergency management
and immediate past president national emergency management association
SCOTT
R. LILLIBRIDGE, MD, National Center for the Infectious
diseases, Centers for Disease Control and Prevention, Department
of Health and Human Services
May 20, 1999 - Before the Subcommittee on Oversight
and Investigations of the Committee on Commerce House of Representatives.
THE
THREAT OF BIOTERRORISM IN AMERICA: Assessing the adequacy
of the federal law relating to dangerous biological agents
TESTIMONY
OF STEPHEN M. OSTROFF, MD, Associate Director for
Epidemilogic Science, National Center for Infectious Diseases,
Centers for Disease Control and Prevention
April 20, 1999 - Before the Subcommittee on
Technology, Terrorism, and Information, Subcommittee on Youth Violence,
Committee on the Judiciary, US Senate.
STATEMENT
OF JAMES M. HUGHES, MD, Director, National Center
for Infectious Diseases, Centers for Disease Control and Prevention,
Department of Health and Human Services
March 25, 1999
STATEMENT
OF JEFFREY P. KOPLAN, MD, M.P.H., Director, Centers
for Disease Control and Prevention, Department of Health and
Human Services
March 16, 1999 - Joint Hearing before the Subcommittee
on labor, Health and Human Services, and Education, and Related Agencies
Committee on Appropriations and the committee on Veterans' Affairs
United States Senate.
BIOTERRORISM--DOMESTIC
WEAPONS OF MASS DESTRUCTION,
 Also
available in Adobe Acrobat
June 2, 1998 - Before the Subcommittee on
Labor, Health and Human Services, and Education Committee on Appropriations,
US Senate.
STATEMENT
OF JAMES M. HUGHES, MD, Director, National Center
for Infectious Diseases, Centers for Disease Control and Prevention,
Department of Health and Human Services
STATEMENT
OF RICHARD JACKSON, MD, M.P.H., Director, National
Center for Infectious Diseases, Centers for Disease Control and
Prevention, Department of Health and Human Services |
